Simplex Trading’s ObsEva SA Ordinary Shares OBSV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,489
| Closed | – | – | 10461 |
|
|
2023
Q1 | $0 | Sell |
1,489
-68,371
| -98% | -$11.8K | ﹤0.01% | 10626 |
|
|
2022
Q4 | $10K | Sell |
69,860
-9,916
| -12% | -$1.69K | ﹤0.01% | 7597 |
|
|
2022
Q3 | $11K | Sell |
79,776
-20,768
| -21% | -$12.5K | ﹤0.01% | 8202 |
|
|
2022
Q2 | $161K | Buy |
100,544
+39,247
| +64% | +$64.8K | ﹤0.01% | 4906 |
|
|
2022
Q1 | $92K | Buy |
+61,297
| New | +$90.5K | ﹤0.01% | 6278 |
|
|
2021
Q4 | – | Sell |
-42,665
| Closed | -$103K | – | 11779 |
|
|
2021
Q3 | $127K | Hold |
42,665
| – | – | ﹤0.01% | 6283 |
|
|
2021
Q2 | $129K | Sell |
42,665
-16,446
| -28% | -$48.4K | ﹤0.01% | 6369 |
|
|
2021
Q1 | $192K | Buy |
59,111
+46,076
| +353% | +$163K | ﹤0.01% | 4810 |
|
|
2020
Q4 | $27K | Buy |
13,035
+8,632
| +196% | +$18.7K | ﹤0.01% | 6768 |
|
|
2020
Q3 | $10K | Buy |
4,403
+3,096
| +237% | +$8.84K | ﹤0.01% | 6813 |
|
|
2020
Q2 | $7K | Buy |
+1,307
| New | +$4.93K | ﹤0.01% | 6860 |
|
Simplex Trading's OBSV Position: Q2 2023 in Review
Simplex Trading sold out of ObsEva SA Ordinary Shares (OBSV) in Q2 2023, closing a stake of 1,489 shares.
Simplex Trading first reported a position in OBSV in Q2 2020 and held it in 11 quarters. The position peaked at $192K in Q1 2021. 0 funds tracked by Wall St. Rank hold OBSV as of Q2 2023.
- Simplex Trading reported no remaining ObsEva SA Ordinary Shares position as of Q2 2023 after selling out during the quarter.
- Simplex Trading sold 1,489 ObsEva SA Ordinary Shares shares in Q2 2023.
- Simplex Trading first reported a position in ObsEva SA Ordinary Shares in Q2 2020 and held it in 11 quarters.
- Simplex Trading's ObsEva SA Ordinary Shares position peaked at $192K in Q1 2021.
- 0 funds tracked by Wall St. Rank held ObsEva SA Ordinary Shares as of Q2 2023.
Based on Simplex Trading's 13F filing for Q2 2023, filed 4 Aug 2023.